Showing 1 - 1 results of 1 for search 'Andrea Wagenfeld', query time: 0.01s Refine Results
  1. 1
    Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies

    Zabedosertib, a novel interleukin-1 receptor-associated kinase-4 inhibitor, shows a favorable pharmacokinetic and safety profile across multiple phase 1 studies by Maximilian Feldmüller, Stefan J. Jodl, Bart Ploeger, Andrea Wagenfeld, Herbert Wiesinger, Frank S. Zollmann, Stefan Klein, Ruiping Zhang, Beate Rohde, Joachim Höchel

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: